Department of Chemistry & Biochemistry, University of Windsor, Windsor, ON, Canada.
J Ethnopharmacol. 2011 Jan 7;133(1):86-91. doi: 10.1016/j.jep.2010.09.005. Epub 2010 Sep 16.
Dandelion extracts have been used in traditional Native American Medicine and Traditional Chinese Medicine (TCM) for treatment of leukemia and breast cancer; however, the mechanism of action remains unknown. Today, DRE is mainly marketed for management of gastrointestinal and liver disorders. The current study aims to determine the anti-cancer activity of dandelion root extract (DRE) against human leukemia, and to evaluate the specificity and mechanism of DRE-induced apoptosis.
The effect of DRE on cell viability was evaluated using the colorimetric-based WST-1 assay. Apoptotic cell death was monitored by nuclear condensation and confirmed by exposure of phosphatidylserine to outer leaflet of plasma membrane. Activation of caspases was detected using a fluorogenic substrate specific to either caspase-8 or -3. Loss of mitochondrial membrane potential was observed by microscopy using JC-1 dye. The apoptotic effect of DRE was also evaluated on a dominant-negative FADD (Fas-associated death domain) cell line and non-cancerous peripheral blood mononuclear cells (PBMCs).
Aqueous DRE effectively induces apoptosis in human leukemia cell lines in a dose and time dependent manner. Very early activation of caspase-8 and the subsequent activation of caspase-3 indicate that DRE may be inducing extrinsic or receptor-mediated apoptosis. Caspase inhibition rendered this extract ineffective, thus DRE-induced apoptosis is caspase-dependent. Moreover, the dominant-negative FADD cells that are unable to form a complete DISC (death-inducing signaling complex) were resistant to DRE treatment, which further confirms our hypothesis that DRE induces receptor-mediated apoptosis. Interestingly, non-cancerous peripheral blood mononuclear cells (PBMCs) exposed to aqueous DRE under the same treatment conditions as leukemia cells were not significantly affected.
Our results suggest that aqueous DRE contains components that act to induce apoptosis selectively in cultured leukemia cells, emphasizing the importance of this traditional medicine and thus presents a potential novel non-toxic alternative to conventional leukemia therapy.
蒲公英提取物已被用于传统的美洲原住民医学和中医(TCM)中治疗白血病和乳腺癌;然而,其作用机制尚不清楚。如今,DRE 主要用于治疗胃肠道和肝脏疾病。本研究旨在确定蒲公英根提取物(DRE)对人白血病的抗癌活性,并评估 DRE 诱导细胞凋亡的特异性和机制。
使用基于比色的 WST-1 测定法评估 DRE 对细胞活力的影响。通过核浓缩监测凋亡细胞死亡,并通过暴露质膜外叶的磷脂酰丝氨酸来确认。使用针对 caspase-8 或 caspase-3 的荧光底物检测半胱天冬酶的激活。通过使用 JC-1 染料在显微镜下观察线粒体膜电位的丧失。还在具有显性负效 Fas 相关死亡域(FADD)的细胞系和非癌外周血单核细胞(PBMC)上评估了 DRE 的凋亡作用。
水提 DRE 以剂量和时间依赖的方式有效地诱导人白血病细胞系凋亡。caspase-8 的早期激活以及随后 caspase-3 的激活表明,DRE 可能诱导外在或受体介导的细胞凋亡。半胱天冬酶抑制剂使该提取物无效,因此 DRE 诱导的凋亡是半胱天冬酶依赖性的。此外,无法形成完整 DISC(死亡诱导信号复合物)的显性负效 FADD 细胞对 DRE 处理具有抗性,这进一步证实了我们的假设,即 DRE 诱导受体介导的凋亡。有趣的是,在与白血病细胞相同的处理条件下暴露于水提 DRE 的非癌细胞外周血单核细胞(PBMC)未受到显著影响。
我们的结果表明,水提 DRE 含有可选择性诱导培养的白血病细胞凋亡的成分,强调了这种传统医学的重要性,从而为传统白血病治疗提供了一种潜在的新型无毒替代方法。